VACCHI, CATERINA
 Distribuzione geografica
Continente #
NA - Nord America 7.309
EU - Europa 6.845
AS - Asia 3.900
SA - Sud America 621
Continente sconosciuto - Info sul continente non disponibili 191
AF - Africa 136
OC - Oceania 85
Totale 19.087
Nazione #
US - Stati Uniti d'America 6.973
IT - Italia 4.273
SG - Singapore 1.154
CN - Cina 862
GB - Regno Unito 641
SE - Svezia 440
BR - Brasile 429
HK - Hong Kong 381
VN - Vietnam 360
DE - Germania 279
BD - Bangladesh 222
FR - Francia 216
CA - Canada 207
RU - Federazione Russa 206
FI - Finlandia 181
IN - India 159
NL - Olanda 153
TR - Turchia 141
JP - Giappone 137
KR - Corea 117
ID - Indonesia 97
UA - Ucraina 86
AU - Australia 77
MX - Messico 74
IE - Irlanda 64
AR - Argentina 63
BG - Bulgaria 59
PK - Pakistan 48
TN - Tunisia 47
PL - Polonia 43
EC - Ecuador 38
IQ - Iraq 35
MY - Malesia 33
ZA - Sudafrica 30
ES - Italia 27
LT - Lituania 26
CO - Colombia 22
CL - Cile 20
PE - Perù 20
AT - Austria 19
AE - Emirati Arabi Uniti 16
EG - Egitto 16
IR - Iran 16
SA - Arabia Saudita 16
JO - Giordania 15
VE - Venezuela 14
BE - Belgio 13
HU - Ungheria 13
PT - Portogallo 13
DK - Danimarca 12
CH - Svizzera 11
PH - Filippine 11
TH - Thailandia 11
KE - Kenya 10
RO - Romania 10
CR - Costa Rica 9
DZ - Algeria 9
IL - Israele 9
NP - Nepal 9
BZ - Belize 8
CZ - Repubblica Ceca 8
LU - Lussemburgo 8
MA - Marocco 8
NZ - Nuova Zelanda 8
OM - Oman 8
PY - Paraguay 8
TW - Taiwan 8
HN - Honduras 7
UZ - Uzbekistan 7
HR - Croazia 6
JM - Giamaica 6
RS - Serbia 6
BO - Bolivia 5
AZ - Azerbaigian 4
BY - Bielorussia 4
CY - Cipro 4
GR - Grecia 4
MD - Moldavia 4
TT - Trinidad e Tobago 4
AL - Albania 3
BB - Barbados 3
DO - Repubblica Dominicana 3
EE - Estonia 3
GT - Guatemala 3
LV - Lettonia 3
NI - Nicaragua 3
PA - Panama 3
PS - Palestinian Territory 3
SY - Repubblica araba siriana 3
AO - Angola 2
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
ET - Etiopia 2
EU - Europa 2
GY - Guiana 2
KG - Kirghizistan 2
KW - Kuwait 2
LB - Libano 2
MN - Mongolia 2
MU - Mauritius 2
Totale 18.869
Città #
Singapore 779
Santa Clara 754
Ashburn 735
Fairfield 591
Chandler 419
Hong Kong 364
San Jose 356
Milan 335
Rome 306
Southend 285
Council Bluffs 264
Woodbridge 262
Nyköping 245
Houston 207
Hefei 183
Wilmington 176
Seattle 173
Beijing 172
London 167
Cambridge 162
Helsinki 155
New York 154
Los Angeles 151
Ann Arbor 141
The Dalles 121
Chicago 106
Bologna 102
Ho Chi Minh City 91
Seoul 88
Hanoi 87
Naples 83
San Diego 72
Florence 71
Jacksonville 68
Modena 68
Toronto 68
Jakarta 67
Bari 61
Catania 59
Dallas 58
Shanghai 58
Sofia 57
Dearborn 55
Palermo 52
Redwood City 52
Dublin 50
Tokyo 50
Bremen 49
Buffalo 49
Princeton 49
Moscow 47
Perth 47
Frankfurt am Main 44
Turin 44
Lauterbourg 42
São Paulo 42
Munich 41
Verona 39
Salt Lake City 38
North York 37
Genoa 36
Orem 36
Cagliari 32
Atlanta 30
Columbus 30
Izmir 30
Eugene 27
Manchester 27
Chennai 26
Padova 25
Falls Church 24
Guayaquil 24
Ankara 23
Istanbul 23
Mexico City 23
Salerno 23
Warsaw 23
Mumbai 22
Parma 22
Da Nang 21
Phoenix 21
Boardman 19
Denver 19
Reggio Emilia 19
Venice 19
Boston 18
Brescia 18
Rio de Janeiro 18
Bergamo 17
Brooklyn 17
Tampa 17
Treviso 17
Elk Grove Village 16
Haiphong 16
Johannesburg 16
Pisa 16
Santiago 16
Baghdad 15
Delhi 15
Montreal 15
Totale 10.619
Nome #
INTERSTIZIOPATIA POLMONARE NON CLASSIFICABILE O SECONDARIA A CONNETTIVITE INDIFFERENZIATA. IMPORTANZA E DIFFICOLTÀ DI UNA DIAGNOSI DIFFERENZIALE. 3.885
Epidemiology and management of interstitial lung disease in ANCA-associated vasculitis 1.381
COVID-19-associated vasculitis and thrombotic complications: from pathological findings to multidisciplinary discussion 523
Radiological thymus alterations in systemic sclerosis: our experience and a review of the literature. 380
Breast cancer in systemic sclerosis: Results of a cross-linkage of an Italian Rheumatologic Center and a population-based Cancer Registry and review of the literature 375
Combination Therapy with Nintedanib and Sarilumab for the Management of Rheumatoid Arthritis Related Interstitial Lung Disease 354
Established coronary artery disease in systemic sclerosis compared to type 2 diabetic female patients: a cross-sectional study 350
INTERSTITIAL LUNG DISEASE RELATED TO RHEUMATOID ARTHRITIS. WHAT DO WE DON’T KNOW? THE LIRA STUDY (LUNG INVOLVEMENT IN RHEUMATOID ARTHRITIS) 349
Acute exacerbation of interstitial lung diseases secondary to systemic rheumatic diseases: A prospective study and review of the literature 332
Gynaecological Screening for Cervical and Vulvar Malignancies in a Cohort of Systemic Sclerosis Patients: Our Experience and Review of the Literature 327
Lung cancer in scleroderma: results from an Italian rheumatologic center and review of the literature. 322
Efficacy and safety of mycophenolate mofetil in the treatment of rheumatic disease-related interstitial lung disease: a narrative review 312
Interstitial pneumonia with autoimmune features: A single center prospective follow-up study 306
Safety of Abatacept in Italian Patients with Rheumatoid Arthritis and Interstitial Lung Disease: A Multicenter Retrospective Study 306
COST ANALYSIS RELATED TO SUBCUTANEOUS IMMUNOGLOBULINS IN PATIENTS WITH INFLAMMATORY MYOPATHIES AND IMMUNE-MEDIATED CHRONIC NEUROPATHIES. RESULTS OF AN OPEN LABEL STUDY 304
Interstitial pneumonia with autoimmune features and undifferentiated connective tissue disease: Our interdisciplinary rheumatology-pneumology experience, and review of the literature 296
CLINICAL AND PATHOLOGICAL FEATURES OF BREAST CANCER IN PATIENTS WITH SYSTEMIC SCLEROSIS: PRELIMINARY DATA FROM THE SCLERO-BREAST STUDY 296
Haematological Malignancies in Systemic Sclerosis Patients: Case Reports and Review of the World Literature 291
AB1157 VALIDATION OF VECTOR (VELCRO CRACKLES DETECTOR) FOR THE DIAGNOSIS OF INTERSTITIAL LUNG DISEASE IN PATIENTS WITH CONNECTIVE TISSUE DISEASES 289
UNCLASSIFIABLE INTERSTITIAL LUNG DISEASE OR UNDIFFERENTIATED CONNECTIVE TISSUE DISEASE? A CHALLENGING DIFFERENTIAL DIAGNOSIS 280
PREVALENZA, CORRELATI CLINICO-SEROLOGICI E CARATTERISTICHE RADIOLOGICHE DELL'INTERSTIZIOPATIA POLMONARE IN UN'AMPIA COORTE DI PAZIENTI AFFETTI DA SINDROME DI SJOGREN 272
Therapeutic Options for the Treatment of Interstitial Lung Disease Related to Connective Tissue Diseases. A Narrative Review 262
Clinical and Pathological Features of Breast Cancer in Systemic Sclerosis: Results from the Sclero-Breast Study 257
RHEUMATOID ARTHRITIS RELATED INTERSTITIAL LUNG DISEASE. RADIOLOGICAL PATTERNS AND CORRELATIONS WITH CLINICAL, SEROLOGICAL AND DEMOGRAPHIC FEATURES OF DISEASE 251
Classification of pulmonary sounds through deep learning for the diagnosis of interstitial lung diseases secondary to connective tissue diseases 248
AB0472 PRIMARY SJOGREN SYNDROME ASSOCIATED INTERSTITIAL LUNG DISEASE: FEATURES, TREATMENT AND OUTCOME OF A MONOCENTRIC COHORT 247
AB0624 SAFETY OF RITUXIMAB BIOSIMILAR FOR THE TREATMENT OF CRYOGLOBULINEMIC VASCULITIS 244
Procedural pain management in the treatment of scleroderma digital ulcers 237
COVID-19 vaccination rate and safety profile in a multicentre Italian population affected by mixed cryoglobulinaemic vasculitis 235
Efficacy and safety of rituximab in the treatment of connective tissue disease-related interstitial lung disease 234
PAP-TEST FEATURES IN A COHORT OF SYSTEMIC SCLEROSIS PATIENTS 233
Erratum: Acute exacerbation of interstitial lung diseases secondary to systemic rheumatic diseases: A prospective study and review of the literature (Journal of Thoracic Disease (2019) 11 (1621-1628) DOI: 10.21037/jtd.2019.03.28) 223
CHARACTERIZATION OF ANTI-MPO POSITIVE INTERSTITIAL LUNG DISEASE. CLINICAL-SEROLOGIC AND RADIOLOGIC FEATURES AND SURVIVAL 210
Usefulness of digital velcro crackles detection in identification of interstitial lung disease in patients with connective tissue diseases 208
VECTOR: An algorithm for the detection of COVID-19 pneumonia from velcro-like lung sounds 208
Molecular Pathways of Breast Cancer in Systemic Sclerosis: Exploratory Immunohistochemical Analysis from the Sclero-Breast Study 206
FRI0613 THERAPEUTIC STRATEGIES AND SURVIVAL IN PATIENTS WITH INTERSTITIAL PNEUMONIA WITH AUTOIMMUNE FEATURES 205
Pirfenidone for the treatment of interstitial lung disease associated to rheumatoid arthritis: a new scenario is coming? 203
Safety and effectiveness of biosimilar of Rituximab CT-P10 in the treatment of cryoglobulinemic vasculitis: the MARBLe study (Mixed cryoglobulinemiA Rituximab BiosimiLar) 202
Tofacitinib for the Treatment of Severe Interstitial Lung Disease Related to Rheumatoid Arthritis 201
Vasculitis in a patient with mixed cryoglobulinemia treated with rituximab biosimilar CT-P10: a case report 189
Treatment of Rheumatoid Arthritis-Associated Interstitial Lung Disease: Lights and Shadows 189
THU0289 PERSISTENCE OF CIRCULATING CRYOGLOBULINS AND RELATED SYMPTOMS AFTER HEPATITIS C VIRUS ERADICATION IN PATIENTS WITH MIXED CRYOGLOBULIN SYNDROME 187
Diagnosis, Clinical Features and Management of Interstitial Lung Diseases in Rheumatic Disorders: Still a Long Journey 183
Fibrosing interstitial lung disease in primary Sjogren syndrome 179
Interstitial pneumonia with autoimmune features: Why rheumatologist–pulmonologist collaboration is essential 173
ACCERTAMENTO DELLA DISABILITÀ NELLE MALATTIE REUMATOLOGICHE (EX L.R. N.4 DEL 19 FEBBRAIO 2008) PROPOSTA DI PROTOCOLLO ORGANIZZATIVO 172
Pathogenesis and treatment of idiopathic and rheumatoid arthritis-related interstitial pneumonia. The possible lesson from COVID-19 pneumonia 159
Erratum: Unusual association between Budd-Chiari syndrome secondary to antiphospholipid syndrome and relapsing polychondritis: A case report and review of the literature (Clinical Rheumatology (2013) 32 (905-907) DOI: 10.1007/s10067-013-2229-z) 156
Pneumopathie interstitielle fibrosante dans le syndrome de Gougerot-Sjögren primitif 148
Fibrosing Progressive Interstitial Lung Disease in Rheumatoid Arthritis: A Multicentre Italian Study 147
COVID-19 VACCINATION RATE AND SAFETY PROFILE IN PATIENTS AFFECTED BY MIXED CRYOGLOBULINEMIC VASCULITIS 141
SAT0470 Pap-Test Features in a Cohort of Systemic Sclerosis Patients 138
Therapeutic Strategies and Survival in Patients with Interstitial Pneumonia with Autoimmune Features 132
POS1053 PREVALENCE OF FIBROSING PROGRESSIVE INTERSTITIAL LUNG DISEASE IN RHEUMATOID ARTHRITIS PATIENTS 124
Reply to “ Sjögren's syndrome and pulmonary hypertension: Correspondence” 122
Sjögren's syndrome and pulmonary hypertension: Exploring the intricate link with interstitial lung disease 116
Rheumatoid arthritis extra-articular lung disease: new insights on pathogenesis and experimental drugs 108
Reply to “Considerations on Patient Age in the Study of Pulmonary Hypertension and Interstitial Lung Disease in Sjögren's Syndrome” 99
PROPOSAL OF CORE OUTCOME DOMAINS IN MIXED CRYOGLOBULINEMIC VASCULITIS 99
Real-World Use of Anifrolumab for Articular Involvement in Systemic Lupus Erythematosus: A Monocentric Case Series and Systematic Review 76
Personalized Medicine and Machine Learning: A Roadmap for the Future 64
Hemoglobin-to-Red Cell Distribution Width Ratio and Vitamin D Status as Early Predictors of Cardiovascular Risk in Primary Sjögren’s Syndrome 58
Beyond systemic lupus erythematosus: a systematic review on the use of belimumab in other connective tissue diseases and vasculitides 57
HCV-related cryoglobulinemic vasculitis (mixed cryoglobulinemia syndrome) in the era of direct-acting antivirals: A 10-year experience from Italian tertiary referral centers 27
Totale 19.087
Categoria #
all - tutte 65.713
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 65.713


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.481 0 83 106 92 113 145 87 87 183 118 243 224
2022/20232.350 235 187 153 161 227 208 165 236 240 133 243 162
2023/20242.467 126 138 165 256 275 252 237 348 75 128 215 252
2024/20253.679 187 117 159 260 589 499 355 227 376 153 327 430
2025/20265.623 359 201 413 654 781 415 649 279 574 499 471 328
2026/2027501 160 341 0 0 0 0 0 0 0 0 0 0
Totale 19.087